vs
尼尔森IQ(NIQ)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
尼尔森IQ的季度营收约是REPLIGEN CORP的1.0倍($204.2M vs $197.9M),尼尔森IQ净利率更高(88.6% vs 6.7%,领先81.9%)
NIQ(尼尔森IQ)是全球领先的消费者行为洞察、零售数据分析与市场测量服务提供商,业务覆盖100余个国家和地区,服务快消品牌、零售商及传媒机构,为客户提供数据驱动的决策支持。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
NIQ vs RGEN — 直观对比
营收规模更大
NIQ
是对方的1.0倍
$197.9M
净利率更高
NIQ
高出81.9%
6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $204.2M | $197.9M |
| 净利润 | $180.8M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 88.6% | 6.7% |
| 营收同比 | — | 13.6% |
| 净利润同比 | — | 143.9% |
| 每股收益(稀释后) | $0.83 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
NIQ
RGEN
| Q4 25 | $204.2M | $197.9M | ||
| Q3 25 | $205.1M | $188.8M | ||
| Q2 25 | $213.4M | $182.4M | ||
| Q1 25 | $221.8M | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | $207.3M | $154.9M | ||
| Q2 24 | $212.4M | $154.1M | ||
| Q1 24 | $207.4M | $151.3M |
净利润
NIQ
RGEN
| Q4 25 | $180.8M | $13.3M | ||
| Q3 25 | $-16.2M | $14.9M | ||
| Q2 25 | $110.3M | $14.9M | ||
| Q1 25 | $23.7M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $16.7M | $-654.0K | ||
| Q2 24 | $-48.6M | $3.3M | ||
| Q1 24 | $14.2M | $2.1M |
毛利率
NIQ
RGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率
NIQ
RGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | 24.2% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 21.7% | -5.1% | ||
| Q2 24 | -10.5% | 1.0% | ||
| Q1 24 | 19.0% | 1.3% |
净利率
NIQ
RGEN
| Q4 25 | 88.6% | 6.7% | ||
| Q3 25 | -7.9% | 7.9% | ||
| Q2 25 | 51.7% | 8.2% | ||
| Q1 25 | 10.7% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 8.1% | -0.4% | ||
| Q2 24 | -22.9% | 2.2% | ||
| Q1 24 | 6.8% | 1.4% |
每股收益(稀释后)
NIQ
RGEN
| Q4 25 | $0.83 | $0.24 | ||
| Q3 25 | $-0.07 | $0.26 | ||
| Q2 25 | $0.50 | $0.26 | ||
| Q1 25 | $0.11 | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | $0.08 | $-0.01 | ||
| Q2 24 | $-0.22 | $0.06 | ||
| Q1 24 | $0.06 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $36.8M | $767.6M |
| 总债务越低越好 | $3.0B | $542.2M |
| 股东权益账面价值 | $3.1B | $2.1B |
| 总资产 | $6.7B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.98× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
NIQ
RGEN
| Q4 25 | $36.8M | $767.6M | ||
| Q3 25 | $68.7M | $748.7M | ||
| Q2 25 | $182.0M | $708.9M | ||
| Q1 25 | $49.1M | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | $467.5M | $784.0M | ||
| Q2 24 | $273.8M | $809.1M | ||
| Q1 24 | $348.6M | $780.6M |
总债务
NIQ
RGEN
| Q4 25 | $3.0B | $542.2M | ||
| Q3 25 | $2.9B | $537.9M | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $2.9B | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.0B | — | ||
| Q1 24 | $3.2B | — |
股东权益
NIQ
RGEN
| Q4 25 | $3.1B | $2.1B | ||
| Q3 25 | $3.2B | $2.1B | ||
| Q2 25 | $3.3B | $2.1B | ||
| Q1 25 | $3.3B | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $3.3B | $2.0B | ||
| Q2 24 | $3.4B | $2.0B | ||
| Q1 24 | $3.5B | $2.0B |
总资产
NIQ
RGEN
| Q4 25 | $6.7B | $2.9B | ||
| Q3 25 | $6.6B | $2.9B | ||
| Q2 25 | $6.9B | $2.9B | ||
| Q1 25 | $6.7B | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $7.1B | $2.8B | ||
| Q2 24 | $7.0B | $2.9B | ||
| Q1 24 | $7.2B | $2.8B |
负债/权益比
NIQ
RGEN
| Q4 25 | 0.98× | 0.26× | ||
| Q3 25 | 0.93× | 0.26× | ||
| Q2 25 | 0.91× | — | ||
| Q1 25 | 0.89× | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | 0.97× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势,按日历期对齐
经营现金流
NIQ
RGEN
| Q4 25 | — | $25.7M | ||
| Q3 25 | $116.2M | $48.1M | ||
| Q2 25 | $132.8M | $28.6M | ||
| Q1 25 | $74.1M | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | — | $49.3M | ||
| Q2 24 | — | $42.2M | ||
| Q1 24 | $53.6M | $44.7M |
自由现金流
NIQ
RGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率
NIQ
RGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度
NIQ
RGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率
NIQ
RGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 1.20× | 1.92× | ||
| Q1 25 | 3.12× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 3.79× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图